Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2000 2
2003 1
2006 1
2007 1
2008 3
2009 1
2010 2
2011 2
2012 2
2013 4
2014 1
2015 2
2016 2
2017 1
2019 2
2020 2
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Transcriptome analysis reveals tumor microenvironment changes in glioblastoma.
Hoogstrate Y, Draaisma K, Ghisai SA, van Hijfte L, Barin N, de Heer I, Coppieters W, van den Bosch TPP, Bolleboom A, Gao Z, Vincent AJPE, Karim L, Deckers M, Taphoorn MJB, Kerkhof M, Weyerbrock A, Sanson M, Hoeben A, Lukacova S, Lombardi G, Leenstra S, Hanse M, Fleischeuer REM, Watts C, Angelopoulos N, Gorlia T, Golfinopoulos V, Bours V, van den Bent MJ, Robe PA, French PJ. Hoogstrate Y, et al. Among authors: hanse m. Cancer Cell. 2023 Apr 10;41(4):678-692.e7. doi: 10.1016/j.ccell.2023.02.019. Epub 2023 Mar 9. Cancer Cell. 2023. PMID: 36898379 Free article.
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Taal W, Oosterkamp HM, Walenkamp AM, Dubbink HJ, Beerepoot LV, Hanse MC, Buter J, Honkoop AH, Boerman D, de Vos FY, Dinjens WN, Enting RH, Taphoorn MJ, van den Berkmortel FW, Jansen RL, Brandsma D, Bromberg JE, van Heuvel I, Vernhout RM, van der Holt B, van den Bent MJ. Taal W, et al. Among authors: hanse mc. Lancet Oncol. 2014 Aug;15(9):943-53. doi: 10.1016/S1470-2045(14)70314-6. Epub 2014 Jul 15. Lancet Oncol. 2014. PMID: 25035291 Clinical Trial.
Glioma patient-reported outcomes: patients and clinicians.
Peeters M, Ottenheijm G, Bienfait P, Eekers D, Gijtenbeek A, Hanse M, Koekkoek J, van Leeuwen L, Tijssen C, Dirven L, Taphoorn M. Peeters M, et al. Among authors: hanse m. BMJ Support Palliat Care. 2023 Oct;13(e1):e205-e212. doi: 10.1136/bmjspcare-2020-002699. Epub 2021 Mar 2. BMJ Support Palliat Care. 2023. PMID: 33653735
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis.
Hoogstrate Y, Ghisai SA, de Wit M, de Heer I, Draaisma K, van Riet J, van de Werken HJG, Bours V, Buter J, Vanden Bempt I, Eoli M, Franceschi E, Frenel JS, Gorlia T, Hanse MC, Hoeben A, Kerkhof M, Kros JM, Leenstra S, Lombardi G, Lukacova S, Robe PA, Sepulveda JM, Taal W, Taphoorn M, Vernhout RM, Walenkamp AME, Watts C, Weller M, de Vos FYF, Jenster GW, van den Bent M, French PJ. Hoogstrate Y, et al. Among authors: hanse mc. Neuro Oncol. 2022 Mar 12;24(3):429-441. doi: 10.1093/neuonc/noab231. Neuro Oncol. 2022. PMID: 34608482 Free PMC article.
The essential role of lipids in Alzheimer's disease.
Florent-Béchard S, Desbène C, Garcia P, Allouche A, Youssef I, Escanyé MC, Koziel V, Hanse M, Malaplate-Armand C, Stenger C, Kriem B, Yen-Potin FT, Olivier JL, Pillot T, Oster T. Florent-Béchard S, et al. Among authors: hanse m. Biochimie. 2009 Jun;91(6):804-9. doi: 10.1016/j.biochi.2009.03.004. Epub 2009 Mar 18. Biochimie. 2009. PMID: 19303044 Free article. Review.
Patients with primary brain tumors and COVID-19: A report from the Dutch Oncology COVID-19 Consortium.
de Joode K, Taal W, Snijders TJ, Hanse M, Koekkoek JAF, Oomen-de Hoop E, de Groot JWB, Kouwenhoven MCM, Beerepoot LV, Dingemans AC, van den Bent MJ, van der Veldt AAM; DOCC Investigators. de Joode K, et al. Among authors: hanse m. Neuro Oncol. 2022 Feb 1;24(2):326-328. doi: 10.1093/neuonc/noab258. Neuro Oncol. 2022. PMID: 34850157 Free PMC article. No abstract available.
The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab.
Gahrmann R, Smits M, Vernhout RM, Taal W, Kapsas G, de Groot JC, Hanse M, Vos M, Beerepoot LV, Buter J, Flach ZH, van der Holt B, van den Bent M. Gahrmann R, et al. Among authors: hanse m. Neurooncol Adv. 2022 Mar 9;4(1):vdac032. doi: 10.1093/noajnl/vdac032. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35419519 Free PMC article.
34 results